MedPath

An investigation of the efficacy of surgical treatment in patients with cervical myelopathy

Not Applicable
Recruiting
Conditions
cervical myelopathy
Registration Number
JPRN-UMIN000033500
Lead Sponsor
The Jikei University School of Medicine
Brief Summary

Observational study

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
125
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria were as follows: (1) history of cervical surgery; (2) history of cerebral palsy; (3) thoracic spondylotic myelopathy; (4) lumber disc herniation or lumber canal stenosis; (5) cervical radiculopathy; (6) rheumatoid arthritis; (7) destructive spondyloarthritis due to hemodialysis; (8) spinal cord tumor; (9) spinal cord injuries; (10) spinal fusion surgery.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcomes were the clinical evaluation and the image evaluation. We performed these assessments preoperatively and at 3, 6, 12, 18, and 24 months postoperatively.
Secondary Outcome Measures
NameTimeMethod
1) the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) survey: preoperatively and at 3, 6, 12, 18, and 24 months postoperatively 2)the 36-Item Short Form Health Survey (SF-36): preoperatively and at 3, 6, 12, 18, and 24 months postoperatively 3)Pain Vision PS-2100 (Nipro, Osaka, Japan) the current perception threshold (CPT): preoperatively and at 3, 6, 12, 18, and 24 months postoperatively
© Copyright 2025. All Rights Reserved by MedPath